Appeal Court Upholds I-MED Pharma’s Patent Win Against TearLab

The Canadian Federal Court of Appeal confirmed that TearLab’s efforts to keep the I-PEN® Osmolarity System, marketed by I-MED Pharma, off the...

Read More